Clinical pharmacist interventions significantly improved medication adherence (P<0.001) and reduced diastolic blood pressure from 86.62 to 77.73 mmHg in rural hypertensive patients.
RCT (n=56)
Randomized
Do clinical pharmacist interventions improve medication adherence and quality of life in rural hypertensive patients?
Clinical pharmacist interventions, including counseling and telephonic reminders, significantly improve medication adherence, quality of life, and blood pressure control in rural hypertensive patients.
p-value: p=<0.001
Hypertension is the very common chronic disease in rural, urban and semi-urban areas of today's world, which needs continuous monitoring and treatment through out the life. Lack of education, lifestyle modification, and low level of understanding on disease management in rural people will influence directly on their quality of life (QOL). The objective of this study was to know the impact of clinical pharmacist interventions on medication adherence and QOL. It was a prospective, randomized and interventional study. Fifty-six patients were enrolled; only 52 patients completed the study. Interventional group patients received patient counselling, patient information leaflets (PILS), and frequent telephonic reminding. In the baseline, first and second follow-ups, medication adherence and QOL were assessed by using Morisky Medication Adherence Scale (MMAS) and Medication Adherence Report Scale (MARS) Questionnaires and SF-12v2 Quality of life Questionnaire in both the groups. The results showed that systolic blood pressure P value in the second follow-up was 0.086+ when compared to baseline follow-up P value 0.094. The diastolic blood pressure reading of the intervention group at the second follow-up was 77.73 ± 3.63 in mmHg when compared to the baseline, i.e. 86.62 ± 11.35 in mmHg. The MMAS and MARS scores P values were 0.007(**), 1.000, <0.001(**); 0.007, 0.014 and 0.000 at the baseline, first and second follow-ups, respectively. The QOL score P values of physical component scale and mental component scale showed highly significant. This study concluded/showed that the impact of clinical pharmacist provided patient counselling had a positive impact on medication adherence and QOL.
Kv et al. (Sun,) conducted a rct in Hypertension (n=56). Clinical pharmacist interventions (patient counselling, leaflets, telephonic reminders) vs. Standard care / Control group was evaluated on Medication adherence (MMAS and MARS) and Quality of Life (SF-12v2) (p=<0.001). Clinical pharmacist interventions significantly improved medication adherence (P<0.001) and reduced diastolic blood pressure from 86.62 to 77.73 mmHg in rural hypertensive patients.